BiotechTube
Wainamics

Wainamics

San Jose, United States· Est.
wainamics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.5M

Overview

Wainamics operates as a specialized service provider and development partner in the microfluidics space, focusing on diagnostics and complex bioassay integration. Its core value proposition is accelerating time-to-market for clients by offering deep expertise in cartridge design, fluidic control, assay integration, and design for manufacturability. The company has a proven track record with notable partners including NASA and academic institutions, working on applications from space biology to point-of-care CRISPR diagnostics. As a private entity, it follows a B2B service model, reducing technical and programmatic risks for its clients.

DiagnosticsMicrobiome

Technology Platform

Integrated microfluidic design and development expertise, including cartridge engineering, fluidic control, assay integration, and design for manufacturability (DFM).

Funding History

1
Total raised:$3.5M
Seed$3.5M

Opportunities

The growing demand for point-of-care and decentralized diagnostics creates significant opportunity for microfluidic cartridge developers.
Wainamics can capitalize on this by partnering with companies seeking to miniaturize and automate complex molecular and immunoassays.
Their proven experience with high-profile projects serves as a strong marketing tool to attract new clients in both diagnostics and emerging life science tools areas like organ-on-a-chip.

Risk Factors

Revenue is dependent on a project-based service model, leading to potential client concentration and cyclical demand.
Intense competition from other design firms and large CDMOs expanding into microfluidics could pressure margins.
Technical failure on a high-profile client project could damage their reputation as experts in a field where reliability is paramount.

Competitive Landscape

Wainamics competes in the microfluidic design and development services space against other specialized engineering firms and, increasingly, large contract development and manufacturing organizations (CDMOs) that offer integrated services. Their key competitive advantages appear to be deep, focused expertise in assay integration and a proven track record of taking designs to manufacturability, as evidenced by long-term partnerships with entities like NASA.

More companies in Drug Delivery & Formulation →More companies in United States →